4.7 Article

Value of screening for the risk of sudden cardiac death in young competitive athletes

期刊

EUROPEAN HEART JOURNAL
卷 44, 期 12, 页码 1084-1092

出版社

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehad017

关键词

Athlete; Cardiac arrest; Cardiomyopathy; Screening; Sports cardiology

向作者/读者索取更多资源

This study aimed to report the long-term findings of the Italian programme of cardiovascular preparticipation screening (PPS) in young, competitive athletes. The study assessed the diagnostic yield for diseases at risk of sudden cardiac death (SCD), the costs of serial evaluations, and the long-term outcomes of PPS in a large population of Italian children. Over an 11-year study period, 69 children (0.3%) were identified with cardiovascular diseases at risk of SCD, and one child with normal PPS findings experienced an episode of resuscitated cardiac arrest during sports activity.
Aims This study aimed to report the long-term findings of the Italian programme of cardiovascular preparticipation screening (PPS) in young, competitive athletes. Methods and results The study assessed the diagnostic yield for diseases at risk of sudden cardiac death (SCD), the costs of serial evaluations, and the long-term outcomes of PPS in a large population of Italian children (age range, 7-18 years). The PPS was repeated annually and included medical history, physical examination, resting electrocardiogram, and stress testing; additional tests were reserved for athletes with abnormal findings. Over an 11-year study period, 22 324 consecutive children [62% males; mean age, 12 (interquartile range, 10-14) years at first screening] underwent a total of 65 397 annual evaluations (median 2.9/child). Cardiovascular diseases at risk of SCD were identified in 69 children (0.3%) and included congenital heart diseases (n = 17), channelopathies (n = 14), cardiomyopathies (n = 15), non-ischaemic left ventricular scar with ventricular arrhythmias (n = 18), and others (n = 5). At-risk cardiovascular diseases were identified over the entire age range and more frequently in children >= 12 years old (n = 63, 91%) and on repeat evaluation (n = 44, 64%). The estimated cost per diagnosis was 73 312euro. During a follow-up of 7.5 +/- 3.7 years, one child with normal PPS findings experienced an episode of resuscitated cardiac arrest during sports activity (event rate of 0.6/100.000 athletes/year). Conclusion The PPS programme led to the identification of cardiovascular diseases at risk of SCD over the whole study age range of children and more often on repeat evaluations. Among screened children, the incidence of sport-related cardiac arrest during long-term follow-up was low.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Cardiac & Cardiovascular Systems

Sports cardiology: An emerging discipline and research field Comment

Domenico Corrado, Alessandro Zorzi

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Reproducibility of ventricular arrhythmias at exercise testing for prediction of non-ischaemic left ventricular scar in athletes

Giulia Brunetti, Francesca Graziano, Luna Cavigli, Alberto Cipriani, Flavio D'Ascenzi, Barbara Bauce, Kalliopi Pilichou, Martina Perazzolo Marra, Domenico Corrado, Alessandro Zorzi

Summary: The study investigated the role of non-ischaemic left ventricular scar in ventricular arrhythmias in athletes, and tested the diagnostic value of arrhythmia reproducibility in repeated exercise testing. The results showed that athletes with NILVS were more likely to have reproducible arrhythmias in repeated ET, while those without NILVS showed inconsistent arrhythmias in repeat testing.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Clinical Neurology

Multiparametric identification of subclinical atrial fibrillation after an embolic stroke of undetermined source

Alvise Del Monte, Francesco Rivezzi, Enrico Giacomin, Francesco Peruzza, Maurizio Del Greco, Massimiliano Maines, Federico Migliore, Alessandro Zorzi, Federica Viaro, Alessio Pieroni, Andrea La Licata, Claudio Baracchini, Emanuele Bertaglia

Summary: This study evaluated the frequency of subclinical atrial fibrillation (SCAF) detected by implantable cardiac monitors (ICM) in patients with embolic stroke of undetermined source (ESUS). It identified several predictors of SCAF, including abnormal P wave terminal force in lead V1, left atrial end-systolic indexed volume > 34 ml/m(2), and BMI > 25 kg/m(2). A multiparametric evaluation using these predictors has the best accuracy to predict SCAF in ESUS patients.

NEUROLOGICAL SCIENCES (2023)

Biographical-Item Cardiac & Cardiovascular Systems

Obituary for Frank Marcus, outstanding medical scientist of right ventricular dysplasia/cardiomyopathy

Gaetano Thiene, Gianfranco Buja, Barbara Bauce, Domenico Corrado, Cristina Basso, Jeffrey Saffitz

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Scarring/arrhythmogenic cardiomyopathy

Domenico Corrado, Alessandro Zorzi, Alberto Cipriani, Barbara Bauce, Riccardo Bariani, Giulia Brunetti, Francesca Graziano, Manuel De Lazzari, Giulia Mattesi, Federico Migliore, Kalliopi Pilichou, Ilaria Rigato, Stefania Rizzo, Gaetano Thiene, Martina Perazzolo Marra, Cristina Basso

Summary: The term 'arrhythmogenic cardiomyopathy' now includes both right ventricular (ARVC) and left ventricular (LV) involvement, with different phenotypic variants. The disease is characterized by the loss of myocardium and the formation of scar tissue, leading to lethal ventricular arrhythmias and impaired ventricular function. The new 'Padua criteria' incorporate cardiac magnetic resonance imaging findings to improve the diagnosis of S/ACM. Risk stratification and treatment mainly focus on arrhythmic burden and ventricular dysfunction, with implantable cardioverter defibrillator being the most effective life-saving therapy.

EUROPEAN HEART JOURNAL SUPPLEMENTS (2023)

Article Neurosciences

Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei

Aron Emmi, Stefania Rizzo, Luisa Barzon, Michele Sandre, Elisa Carturan, Alessandro Sinigaglia, Silvia Riccetti, Mila Della Barbera, Rafael Boscolo-Berto, Patrizia Cocco, Veronica Macchi, Angelo Antonini, Monica De Gaspari, Cristina Basso, Raffaele De Caro, Andrea Porzionato

Summary: Neurological manifestations are common in COVID-19 patients, and this study found evidence of SARS-CoV-2 infection in the central nervous system. The researchers observed viral RNA and SARS-CoV-2-immunoreactive neurons in specific regions of the brain in COVID-19 patients. In addition, inflammation was observed in affected brainstem regions, indicating a role of brainstem inflammation in COVID-19. Further investigations are needed to understand the potential implications for neurodegenerative diseases like Parkinson's.

NPJ PARKINSONS DISEASE (2023)

Article Cardiac & Cardiovascular Systems

Semi-Quantification of Myocardial Uptake of Bone-Seeking Agents in Suspected Cardiac Amyloidosis

Cristina Campi, Chiara Briani, Alessandro Salvalaggio, Chiara Giraudo, Alberto Cipriani, Alessandro Zorzi, Pietro Zucchetta, Roberto Vettor, Diego Cecchin

Summary: The study introduced a new semi-quantification method for diagnosing ATTR cardiac amyloidosis when SPET/CT is not available, and it showed that the heart-to-thigh ratio (RHT) can accurately distinguish between healthy controls and subjects likely affected by CA especially in the male population.

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2023)

Review Cardiac & Cardiovascular Systems

Evolving spectrum of arrhythmogenic cardiomyopathy: Implications for Sports Cardiology

Francesca Graziano, Alberto Cipriani, Dorottya Balla, Sergei Bondarev, Martina Perazzolo Marra, Barbara Bauce, Hajnalka Vago, Domenico Corrado, Alessandro Zorzi

Summary: Arrhythmogenic cardiomyopathy (ACM) is a genetic heart muscle disease characterized by progressive fibro-fatty replacement of the normal myocardium and ventricular arrhythmias (VAs). Sport activity can worsen ACM and may lead to life-threatening VAs and sudden cardiac death (SCD). Early identification of affected athletes through preparticipation screening (PPS) is crucial, and exercise testing can improve the diagnostic yield of PPS. Patients with ACM are not eligible for competitive sports, but low-to-moderate intensity physical activity under medical supervision is possible in most cases.

CLINICAL CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Interpretation and management of premature ventricular beats in athletes: An expert opinion document of the Italian Society of Sports Cardiology (SICSPORT)

Alessandro Zorzi, Flavio 'Ascenzi, Daniele Andreini, Silvia Castelletti, Michela Casella, Elena Cavarretta, Alberto Cipriani, Paolo Compagnucci, Pietro Delise, Antonio Dello Russo, Francesca Graziano, Zefferino Palam, Antonio Pelliccia, Patrizio Sarto, Domenico Corrado, Luigi Sciarra

Summary: In this expert opinion document, the Italian Society of Sports Cardiology proposes a multiparametric interpretation approach and stepwise diagnostic algorithm for premature ventricular beats (PVBs) in athletes. Most athletes can be reassured of the benign nature of PVBs and cleared for competition based on initial evaluations. However, high clinical suspicion may require further non-invasive and invasive tests to rule out high-risk conditions.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

Letter Cardiac & Cardiovascular Systems

The impact of the Italian law mandating an automatic external defibrillator in all sports venues on sudden cardiac arrest resuscitation rates

Alessandro Gianni, Marco Botteri, Giuseppe Stirparo, Giulia Mattesi, Alessandro Zorzi, Guido Francesco Villa

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Review Biochemistry & Molecular Biology

Desmosomal Arrhythmogenic Cardiomyopathy: The Story Telling of a Genetically Determined Heart Muscle Disease

Gaetano Thiene, Cristina Basso, Kalliopi Pilichou, Maria Bueno Marinas

Summary: Arrhythmogenic cardiomyopathy (AC) is a genetically determined desmosomal disease, which was discovered in a four-generation family in 1728. At the University of Padua, further research on AC was conducted, leading to the identification of specific diagnostic methods and the discovery of the genes responsible for the disease. The advancements in knowledge have also resulted in the prevention of sudden cardiac death and the identification of asymptomatic carriers through genetic screening.

BIOMEDICINES (2023)

Article Cardiac & Cardiovascular Systems

Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies A Pilot Report

Giovanni Peretto, Giacomo De Luca, Andrea Villatore, Chiara Di Resta, Simone Sala, Anna Palmisano, Davide Vignale, Corrado Campochiaro, Davide Lazzeroni, Monica De Gaspari, Stefania Rizzo, Elena Busnardo, Paola Ferro, Luigi Gianolli, Cristina Basso, Lorenzo Dagna, Antonio Esposito, Sara Benedetti, Paolo Della Bella

Summary: This article presents a clinical report on the overlap between myocarditis and genetic cardiomyopathies. Through extensive baseline characterization and prospective reassessment of 25 patients, the authors demonstrated that multimodal imaging can distinguish specific genotypes and identify myocardial inflammation. Additionally, they showed that immunomodulatory therapy was beneficial for most patients.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2023)

Article Cardiac & Cardiovascular Systems

Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic Cardiomyopathy

Giovanni Peretto, Michela Casella, Marco Merlo, Sara Benedetti, Stefania Rizzo, Chiara Cappelletto, Chiara Di Resta, Paolo Compagnucci, Monica De Gaspari, Antonio Dello Russo, Giorgio Casari, Cristina Basso, Simone Sala, Gianfranco Sinagra, Paolo Della Bella, Leslie T. Cooper Jr

Summary: This study aimed to investigate the prognostic value of genetic testing and histology in a cohort of patients with undefined left ventricular arrhythmogenic cardiomyopathy (ULVACM). The study found that malignant ventricular arrhythmias and active myocardial inflammation were closely associated with the occurrence of major adverse cardiovascular events (MACE). Furthermore, immunosuppressive therapy was found to be negatively associated with MACE at 60 months.

JACC-CLINICAL ELECTROPHYSIOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Cardiac magnetic resonance imaging of arrhythmogenic cardiomyopathy: evolving diagnostic perspectives

Alberto Cipriani, Giulia Mattesi, Riccardo Bariani, Annagrazia Cecere, Nicolo Martini, Laura De Michieli, Stefano Da Pozzo, Simone Corradin, Giorgio De Conti, Alessandro Zorzi, Raffaella Motta, Manuel De Lazzari, Barbara Bauce, Sabino Iliceto, Cristina Basso, Domenico Corrado, Martina Perazzolo Marra

Summary: Arrhythmogenic cardiomyopathy (ACM) is a genetically determined heart muscle disease characterized by fibro-fatty myocardial replacement, clinically associated with malignant ventricular arrhythmias and sudden cardiac death. Cardiac magnetic resonance (CMR) has emerged as the key imaging technique for the diagnosis of ACM, providing detailed evaluation of both right ventricular (RV) and left ventricular (LV) morphology, function, and tissue characteristics, as well as supplemental value for disease variants.

EUROPEAN RADIOLOGY (2023)

暂无数据